Qudian Inc. (QD) Forms $13.75 Double Bottom; RHOEN KLINIKUM AKT (RHKJF) Shorts Decreased By 11.46%

Qudian Inc. (QD) formed double bottom with $13.06 target or 5.00% below today’s $13.75 share price. Qudian Inc. (QD) has $4.54B valuation. The stock increased 5.36% or $0.7 during the last trading session, reaching $13.75. About 2.78 million shares traded. Qudian Inc. (NYSE:QD) has 0.00% since January 24, 2017 and is . It has underperformed by 16.70% the S&P500.

RHOEN KLINIKUM AKT (OTCMKTS:RHKJF) had a decrease of 11.46% in short interest. RHKJF’s SI was 25,500 shares in January as released by FINRA. Its down 11.46% from 28,800 shares previously. With 100 avg volume, 255 days are for RHOEN KLINIKUM AKT (OTCMKTS:RHKJF)’s short sellers to cover RHKJF’s short positions. It closed at $35.09 lastly. It is down 0.00% since January 24, 2017 and is . It has underperformed by 16.70% the S&P500.

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. The company has market cap of $2.45 billion. The Company’s hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases. It has a 1253.21 P/E ratio. As of April 7, 2017, it operated 5 medical sites with a total of 5,300 beds.